Strides Pharma Science Limited has informed the Exchange about Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Limited has submitted regulatory compliance certificates for Q4 FY26 (quarter ended March 31, 2026) as required under SEBI regulation 74(5). The certificates were issued by KFin Technologies Limited, the company's Registrar and Share Transfer Agent, and confirm that dematerialization and rematerialization details for securities have been furnished to both depositories — NSDL and CDSL — and the stock exchanges. This is a standard procedural filing to ensure compliance with SEBI depository regulations. No new or material information is disclosed in this announcement.
This is a routine regulatory filing with no direct impact on the stock price or shareholder value. It merely confirms continued compliance with SEBI's depository requirements.